Dr. Ram Aiyar is the CEO of Korro Bio, Inc., a company focused on innovative biopharmaceutical solutions. He has a strong educational background with an MBA from INSEAD, a PhD from Drexel University, and a bachelor's degree in electronics engineering...
Dr. Ram Aiyar is the CEO of Korro Bio, Inc., a company focused on innovative biopharmaceutical solutions. He has a strong educational background with an MBA from INSEAD, a PhD from Drexel University, and a bachelor's degree in electronics engineering from Mumbai University. Before leading Korro, he co-founded Corvidia Therapeutics, where he also served as the Chief Financial Officer. Aiyar has experience in various leadership roles in corporate development and product management for companies like Johnson & Johnson and J.P. Morgan. He is currently involved in insider trading activities that reflect his confidence in Korro Bio, showing a range of stock value fluctuations from about $6.21 million in November 2023 to $11.43 million in April 2024. His new employment agreement includes a base salary of $498,487 with a target bonus tied to performance, indicating a strong alignment with company growth and strategy. Dr. Aiyar's career reflects a blend of deep knowledge in biopharmaceutical processes and practical business strategy, making him well-suited to guide Korro in its mission to innovate in the healthcare space.